A randomized, double-blind, phase III non-inferiority clinical trial to assess efficacy and safety of triamcinolone acetonide nasal spray in comparison with fluticasone propionate nasal spray in adults suffering from perennial allergic rhinitis (PAR) in Russia: a post-hoc analysis of Quality of Life